Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
BOSTON – The American Thyroid Association (ATA) has released new guidelines regarding radioactive iodine use in thyroid cancer treatment. Although new evidence suggests that radioactive iodine should not be used for all patients, there is some controversy with the new guidelines.
Megan Haymart, MD, from the University of Michigan discusses the new recommendations for radioactive iodine use in patients with low risk for thyroid cancer in this video from ENDO 2016.
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Endocrinology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Endocrinology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.